3-hydroxyflavone has been researched along with Osteoporosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collin, A; de Barboza, GD; Picotto, G; Rivoira, M; Rodríguez, V; Tolosa de Talamoni, N | 1 |
| Bahney, C; Huard, J; Nelson, AL; Nishimura, H; Philippon, MJ; Ravuri, SK; Rutledge, JC; Yamaura, K | 1 |
| Dou, Y; Liang, G; Liu, J; Pan, J; Yang, W; Yang, Y; Zeng, L; Zhao, J | 1 |
| Huang, S; Jin, R; Li, X; Tan, L; Tong, H; Zhang, X | 1 |
| He, X; Qin, L; Xu, L; Yu, K; Yuan, M; Zhang, Q; Zhou, Y | 1 |
| Choi, YH; Kang, CH; Kim, GY; Lee, CM; Lee, MH; Lee, S; Molagoda, IMN | 1 |
| Coxam, V; Guicheux, J; Léotoing, L; Miot-Noirault, E; Wauquier, F; Wittrant, Y | 1 |
| Bhaduaria, S; Chattopadhyay, N; Khan, MP; Kumar, S; Maurya, R; Mishra, JS; Sanyal, S; Sharan, K; Singh, AK; Srivastava, A; Yadav, M | 1 |
3 review(s) available for 3-hydroxyflavone and Osteoporosis
| Article | Year |
|---|---|
Analysis of the Molecular Mechanisms by Flavonoids with Potential Use for Osteoporosis Prevention or Therapy.
Topics: Animals; Anthocyanins; Female; Flavones; Flavonoids; Flavonols; Humans; Osteoporosis | 2022 |
The effects of fisetin on bone and cartilage: A systematic review.
Topics: Animals; Cartilage; Flavonols; Osteoarthritis; Osteoporosis | 2022 |
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
Topics: Animals; Atherosclerosis; Diabetes Mellitus; Flavonols; Gene Expression Regulation; Humans; Hypoglycemic Agents; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Osteoporosis; Signal Transduction | 2020 |
5 other study(ies) available for 3-hydroxyflavone and Osteoporosis
| Article | Year |
|---|---|
Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.
Topics: Drugs, Chinese Herbal; Flavonols; Mesenchymal Stem Cells; Network Pharmacology; Osteogenesis; Osteoporosis; Phosphatidylinositol 3-Kinases; Wnt Signaling Pathway | 2023 |
Connectivity Map Analysis Identifies Fisetin as a Treatment Compound for Osteoporosis Through Activating the PI3K-AKT Signaling Pathway in Mouse Pre-osteoblastic MC3T3-E1 Cells.
Topics: 3T3 Cells; Animals; Cell Differentiation; Flavonols; Mice; Osteoblasts; Osteogenesis; Osteoporosis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2021 |
Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3β phosphorylation at Ser9 and consequent β-catenin activation, inhibiting osteoporosis.
Topics: Animals; Animals, Genetically Modified; beta Catenin; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Flavonols; Glycogen Synthase Kinase 3 beta; Mice; Osteogenesis; Osteoporosis; Phosphorylation; Serine; Zebrafish | 2021 |
The polyphenol fisetin protects bone by repressing NF-κB and MKP-1-dependent signaling pathways in osteoclasts.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Dual Specificity Phosphatase 1; Flavonoids; Flavonols; Gene Expression Regulation; Humans; MAP Kinase Kinase 4; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction | 2013 |
A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Topics: Animals; Apoptosis; Biomechanical Phenomena; Bone and Bones; Bone Density; Female; Flavonols; Glucocorticoids; Glucosides; Male; Mesenchymal Stem Cells; Osteoblasts; Osteocalcin; Osteogenesis; Osteoporosis; Parathyroid Hormone; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Ulmus | 2013 |